SNRPGP16

Across TCGA patient cohorts, SNRPGP16 RNA expression is significantly associated with the go_rna of many other GO terms, with 5,956 significant associations in total. STAD shows the largest number of these associations.

The most reproducible SNRPGP16-associated GO terms across cancer lineages are Peptidyl-lysine modification, Protein processing, and Peptidyl-proline modification. Each is linked with SNRPGP16 in more than 6 cancer types. Because this analysis shows association rather than direction, both SNRPGP16-to-partner and partner-to-SNRPGP16 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Peptidyl-lysine modification grouped by SNRPGP16-low versus SNRPGP16-high in ESCA.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (SNRPGP16→partner) and Y-score (partner→SNRPGP16) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
ESCA	Peptidyl-lysine modification →	+0.114	+0.096	<.001	.002	3	7
ESCA	Protein processing →	+0.100	+0.065	<.001	.004	3	6
STAD	Peptidyl-proline modification →	+0.093	+0.069	<.001	<.001	3	6
ESCA	Blastocyst development →	+0.123	+0.123	<.001	.003	3	6
ESCA	Insulin secretion →	+0.075	+0.145	<.001	.001	3	6
ESCA	Signal transduction in response to DNA damage →	+0.141	+0.070	<.001	.002	3	6

Each partner links to its Q-omics profile. Showing the 6 strongest of 5,956 associations by consensus.

Peptidyl-lysine modification by SNRPGP16 expression — ESCA

Explore this box plot interactively →